You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Guanylate Cyclase-BI 685509
BI 685509

Chemical Structure : BI 685509

CAS No.: 1579514-06-9

BI 685509 (Avenciguat, BI-685509)

Catalog No.: PC-49581Not For Human Use, Lab Use Only.

BI 685509 (Avenciguat) is a potent, selective and orally bioavailable soluble guanylate cyclase (sGC) activator, increases cGMP in human and rat platelet-rich plasma treated with ODQ with EC50 of 467 nM and 304 nM, respectively.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    BI 685509 (Avenciguat) is a potent, selective and orally bioavailable soluble guanylate cyclase (sGC) activator, increases cGMP in human and rat platelet-rich plasma treated with ODQ with EC50 of 467 nM and 304 nM, respectively.
    BI 685509 increased cGMP production with an EC50 of 9.29, 3.52, 4.69, 8.65, and 5.54 nM against the mouse, rat, dog, cynomolgus monkey, and human α2/β1 enzyme, respectively, compared with an EC50 of 6.81 nM against the human α1/β1 enzyme.
    In conscious telemetry-instrumented rats, BI 685509 did not effect mean arterial pressure (MAP) or heart rate (HR) at 3 and 10 mg/kg (p.o.), whereas 30 mg/kg decreased MAP and increased HR.
    BI 685509 at supratherapeutic doses (60 or 100 mg/kg po, qd, 10 days) attenuated MAP and HR responses to a single 100 mg/kg challenge.
    BI 685509 (1, 3, 10, 30 mg/kg/day qd) co-administered with enalapril (3 mg/kg/day) dose-dependently reduced proteinuria and incidence of glomerular sclerosis in the ZSF1 rat model.
    BI 685509 dose-dependently reduced tubulointerstitial fibrosis in the 7-day rat UUO model.

    Physicochemical Properties

    M.Wt 582.70
    Formula C34H38N4O5
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    5-ethoxy-1-(6-(3-methyl-2-((5-methyl-2-(tetrahydro-2H-pyran-4-yl)-1,2,3,4-tetrahydroisoquinolin-6-yl)methoxy)phenyl)pyridin-2-yl)-1H-pyrazole-4-carboxylic acid

    References

    1. Reinhart GA, et al. J Pharmacol Exp Ther. 2022 Dec 6:JPET-AR-2022-001423.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: